- Home
- WFC vs MRK Comparison
WFC vs MRK Comparison
Compare WFC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFC
- MRK
- Stock Information
- Founded
- WFC 1852
- MRK 2000
- Country
- WFC United States
- MRK United States
- Employees
- WFC N/A
- MRK N/A
- Industry
- WFC Major Banks
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- WFC Finance
- MRK Health Care
- Exchange
- WFC Nasdaq
- MRK Nasdaq
- Market Cap
- WFC 249.8B
- MRK 218.2B
- IPO Year
- WFC N/A
- MRK N/A
- Fundamental
- Price
- WFC $62.07
- MRK $78.93
- Analyst Decision
- WFC Buy
- MRK Buy
- Analyst Count
- WFC 19
- MRK 16
- Target Price
- WFC $75.53
- MRK $121.40
- AVG Volume (30 Days)
- WFC 18.2M
- MRK 17.1M
- Earning Date
- WFC 04-11-2025
- MRK 04-24-2025
- Dividend Yield
- WFC 2.41%
- MRK 3.96%
- EPS Growth
- WFC 11.18
- MRK 4714.29
- EPS
- WFC 5.37
- MRK 6.74
- Revenue
- WFC $77,962,000,000.00
- MRK $64,168,000,000.00
- Revenue This Year
- WFC $9.92
- MRK $2.59
- Revenue Next Year
- WFC $4.52
- MRK $6.51
- P/E Ratio
- WFC $12.36
- MRK $12.14
- Revenue Growth
- WFC 0.99
- MRK 6.74
- 52 Week Low
- WFC $50.15
- MRK $76.00
- 52 Week High
- WFC $81.50
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- WFC 29.06
- MRK 22.13
- Support Level
- WFC $58.42
- MRK $85.32
- Resistance Level
- WFC $72.47
- MRK $88.90
- Average True Range (ATR)
- WFC 2.54
- MRK 2.84
- MACD
- WFC -1.03
- MRK -1.23
- Stochastic Oscillator
- WFC 21.52
- MRK 7.89
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.